VU6052959
VU6052959 (BI’7927) is an orally active, blood-brain barrier-penetrant mGlu3 modulator with an EC50 of 36 nM in humans and 16 nM in rats. VU6052959 enhances recognition memory and reverses cognitive impairment in male rats. VU6052959 can be used in the research of schizophrenia.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Formel: C20H17FN4O2
- Molecular Weight:364.37
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
hmGluR3 36 nM (EC50) |
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Parmacokinetics
| Species | Dose | Route | CLplasma | T1/2 | MRT | Vss |
|---|---|---|---|---|---|---|
| Rat[1] | 0.2 mg/kg | i.v. | 19.8 mL/min/kg | 0.8 | 0.9 | 1.1 L/kg |
In Vivo
VU6052959 (3-30 mg/kg; p.o.; single administration) dose-dependently reverses cognitive impairment induced by MK-801 (HY-15084B) and Scopolamine (HY-N0296) in male Sprague-Dawley rats[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sprague-Dawley (male)[1]
-
Dosage:3 mg/kg; 10 mg/kg; 30 mg/kg
-
Administration:p.o.; single dose; 30 minutes prior to object exposure
-
Result:Significantly enhanced recognition index compared to vehicle control at 10 mg/kg.
Produced a larger, highly significant enhancement in recognition index compared to vehicle control at 30 mg/kg.
Reached unbound brain levels of 50.1 nM (≈3.1-fold the rat mGlu3 PAM EC50) at 10 mg/kg.
-
Animal Model:Sprague-Dawley (male; MK-801-induced cognitive impairment)[1]
-
Dosage:3 mg/kg; 10 mg/kg; 30 mg/kg
-
Administration:p.o.; single dose
-
Result:Dose-dependently reversed MK-801-induced deficits in recognition memory.
Produced significant enhancements compared to vehicle + MK-801 control at 3 mg/kg and 10 mg/kg.
-
Animal Model:Sprague-Dawley (male; Scopolamine-induced cognitive impairment)[1]
-
Dosage:3 mg/kg; 10 mg/kg; 30 mg/kg
-
Administration:p.o.; single dose
-
Result:Significantly reversed scopolamine-induced deficits in recognition memory compared to vehicle + scopolamine control at 10 mg/kg.
Produced a larger, highly significant reversal compared to vehicle + scopolamine control at 30 mg/kg.
Chemical Information
-
Molecular Weight 364.37
-
Formel C20H17FN4O2
-
SMILES
FC1=CC=CC([C@H]2COC(C=C(NC(C3=NC=CC=N3)=O)C=C4)=C4N2C)=C1
-
Synonyms
BI’7927
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)